Prof. Stefan Buchholz to head Evonik's R&D group Creavis


Prof. Stefan Buchholz (50) has assumed the position as head of Creavis, the strategic R&D unit of Evonik. Buchholz studied chemistry in Marburg, Germany and received his doctorate from the Max-Planck Institute of Polymer Research in Mainz. He finished his Post-doc at the Harvard University in Boston, USA. In 2011 Buchholz was appointed honorary professor by the University of Stuttgart. Prof. Buchholz began his professional career within Evonik in 1993 as scientific assistant in the business unit Industry and Fine Chemicals of the former Degussa in Frankfurt. From 1998 to 2000 he worked as plant assistant at the Antwerp, Belgium site before he took over management of the Biotechnology Project House at the Hanau site. From 2008 until recently, Prof. Buchholz was Head of Innovation Management in the business unit Advanced Intermediates.
most read

Novo Nordisk's CEO Lars Fruergaard Jørgensen Steps Down
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.

Jens Birgersson Becomes New Brenntag CEO
Jens Birgersson becomes new Brenntag CEO

Orion Announced Plans to Shut Down Carbon Black Plants
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.

Dow to Shut Down Three Upstream European Assets
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.

Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.









